SecSonar.com

Scinai Immunotherapeutics Ltd. (SCNI)

Scinai Immunotherapeutics Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Scinai Immunotherapeutics Ltd. (SCNI) is a Biotechnology company based in IL with a market capitalization of $604.8K. Free cash flow was negative at -$6.1M. This page tracks SCNI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 31 employees · IPO May 11, 2015

Valuation

Valuation & price

$0.54 · as of May 17, 2026 · -77.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.07

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.34$1.30$0.25Jul 25Dec 25Jul 26Jul 7, 25$2.15Jul 9, 25$2.34Jul 11, 25$2.32Jul 15, 25$2.22Jul 17, 25$2.14Jul 21, 25$2.20Jul 23, 25$2.26Jul 25, 25$2.06Jul 29, 25$2.00Jul 31, 25$1.46Aug 4, 25$1.51Aug 6, 25$1.60Aug 11, 25$1.47Aug 13, 25$1.68Aug 15, 25$1.59Aug 19, 25$1.53Aug 21, 25$1.73Aug 25, 25$1.54Aug 27, 25$1.48Aug 29, 25$1.53Sep 3, 25$1.61Sep 5, 25$1.50Sep 9, 25$1.51Sep 11, 25$1.58Sep 16, 25$1.57Sep 18, 25$1.56Sep 22, 25$1.45Sep 24, 25$1.42Sep 26, 25$1.32Sep 30, 25$1.26Oct 2, 25$1.36Oct 6, 25$1.36Oct 8, 25$1.63Oct 10, 25$1.37Oct 14, 25$1.37Oct 16, 25$1.46Oct 21, 25$1.51Oct 23, 25$1.42Oct 27, 25$1.46Oct 29, 25$1.45Oct 31, 25$1.40Nov 4, 25$1.13Nov 6, 25$1.06Nov 10, 25$1.05Nov 12, 25$1.10Nov 14, 25$0.98Nov 18, 25$0.97Nov 20, 25$0.91Nov 25, 25$0.92Nov 28, 25$1.03Dec 2, 25$1.03Dec 4, 25$1.07Dec 8, 25$1.19Dec 10, 25$1.23Dec 12, 25$1.20Dec 16, 25$0.84Dec 18, 25$0.74Dec 22, 25$0.80Dec 24, 25$0.75Dec 29, 25$0.65Jan 2, 26$0.73Jan 6, 26$0.83Jan 8, 26$0.81Jan 12, 26$0.78Jan 14, 26$0.96Jan 16, 26$0.86Jan 21, 26$0.85Jan 23, 26$1.00Jan 27, 26$1.09Jan 29, 26$0.97Feb 2, 26$0.99Feb 4, 26$0.91Feb 9, 26$0.79Feb 11, 26$0.80Feb 13, 26$0.74Feb 18, 26$0.79Feb 20, 26$0.72Feb 24, 26$0.86Feb 26, 26$0.87Mar 2, 26$0.85Mar 4, 26$0.85Mar 6, 26$0.78Mar 10, 26$0.75Mar 12, 26$0.73Mar 17, 26$0.70Mar 19, 26$0.70Mar 23, 26$0.68Mar 25, 26$0.67Mar 27, 26$0.60Mar 31, 26$0.57Apr 2, 26$0.60Apr 7, 26$0.57Apr 9, 26$0.59Apr 13, 26$0.59Apr 15, 26$0.60Apr 17, 26$0.56Apr 22, 26$0.54Apr 24, 26$0.74Apr 28, 26$0.58Apr 30, 26$0.74May 4, 26$0.64May 6, 26$0.57May 8, 26$0.57May 12, 26$0.53May 14, 26$0.53May 18, 26$0.56May 20, 26$0.48May 22, 26$0.46May 28, 26$0.45Jun 1, 26$0.50Jun 3, 26$0.45Jun 5, 26$0.41Jun 9, 26$0.35Jun 11, 26$0.33Jun 15, 26$0.36Jun 17, 26$0.34Jun 22, 26$0.29Jun 24, 26$0.27Jun 26, 26$0.25Jul 2, 26$0.27
$0.2552-week range$2.34
Loading valuation history…

Fundamentals

Key fundamentals

$604.8K

Market cap

—

Revenue growth (YoY)

-202.3%

Gross margin

-$6.1M

Free cash flow (USD)

$606K

Net debt

189.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$658.0KFY 2025$1.3M
$0$1.3M

Free cash flow by year

2016 → 2025

FY 2016$-2.5MFY 2017$-4.2MFY 2018$-21.6MFY 2019$-24.5MFY 2020$-24.5MFY 2021$-7.6MFY 2022$-8.1MFY 2023$-10.0MFY 2024$-6.3MFY 2025$-6.1M
-$2.5M-$6.1M

Gross margin by year

2024 → 2025

FY 2024-88.2%FY 2025-202.3%
-88.2%-202.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 10, 2026 (EPS $0.94)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJun 17, 2026Filing
  • Annual reportAnnual Report FiledJun 15, 2026Filing
  • 6-K filingNotice to ShareholdersJun 8, 2026Filing
  • 6-K filingAnnual General Meeting NoticeMay 12, 2026Filing
  • Annual reportAnnual Report FiledMay 8, 2026Filing
  • 6-K filingSecurities Purchase AgreementApr 27, 2026Filing
  • Annual report20-F FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is Scinai Immunotherapeutics Ltd.'s market cap?

Scinai Immunotherapeutics Ltd. (SCNI) has a market capitalization of $604.8K.

What is SCNI's P/E ratio?

A meaningful P/E ratio is not available for SCNI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SCNI's price-to-book (P/B) ratio?

SCNI trades at 0.07 times book value per share.

When did Scinai Immunotherapeutics Ltd. last report earnings?

SCNI last reported earnings on June 10, 2026; the next date is not yet scheduled.

Are insiders buying SCNI stock?

SEC Form 4 filings show no open-market insider buys at Scinai Immunotherapeutics Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ASBP

Aspire Biopharma Holdings, Inc.

$627.6K

BDRX

Biodexa Pharmaceuticals Plc

$573.7K

SPRC

SciSparc Ltd.

$523.4K

VRAX

Virax Biolabs Group Limited

$769K

ONCO

Onconetix, Inc.

$400.8K

PPBT

Purple Biotech Ltd.

$396K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.